Compare RNAZ & LZM.WS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNAZ | LZM.WS |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Isle of Man |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 32.4M |
| IPO Year | 2021 | N/A |
| Metric | RNAZ | LZM.WS |
|---|---|---|
| Price | $1.40 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.7K | ★ 27.3K |
| Earning Date | 08-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $0.36 |
| 52 Week High | $12.60 | $0.40 |
| Indicator | RNAZ | LZM.WS |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $1.93 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.